Skip to content

Corporate Funding Opportunities

PIVOT Center works with companies to thoroughly understand their R&D goals and match them to research goals of the appropriate faculty members at the University of Utah. PIVOT’s Corporate Engagement team works across all schools and units to facilitate partnerships and offer expertise on identifying opportunities that include grant funding, sponsored research and creating strategic corporate partnerships. PIVOT also provides guidance to faculty for successful stewardship. Please contact Sadhna Kohli (Director of Corporate Engagement) for more information regarding these opportunities, or if you have any questions.

PepsiCo: Removing Organics from Coconut Water to Improve Flavor
Amount: $100,000
Deadline: November 19th, 2021

Coconut water has a positive consumer perception and is lower in sugar than other juices. However, the taste/flavor profile of mature From Concentrate Coconut Water (FC CCW) can be very polarizing due to the presence of specific flavor and taste compounds. Removal of targeted flavor compounds (Aldehydes, Lactones, Benzothiazoles, and Alcohols) will make the product more neutral in taste and juice businesses across the globe can use more FC CCW for sugar reduction in juice blends.

PepsiCo are looking to modify current From Concentrate Coconut Water ingredients to minimize off flavor and the aroma profile making it more neutral in taste, expanding the application potential, and improving juice portfolio margins.

Click here to learn more!

Johnson & Johnson-Immunology Innovations QuickFire Challenge: Precision Medicine in Immune-Mediated Disease
Amount: Up to $500,000
Deadline: January 14, 2022

Specific disease areas of focus for this challenge include gastroenterology, rheumatology, dermatology, fetal-maternal diseases, autoantibody-mediated diseases, and other immune-mediated diseases where a stratified approach has the potential to be transformational for patients. 

Innovators with transformative potential solutions to help or aim to advance precision medicine approaches in immune-mediated diseases are invited to apply. This may include: 

  • Novel approaches toward patient stratification and precision medicine that can be harnessed in immune-mediated diseases including: 
    • Multidimensional biomarker discovery platforms, including those with AI/ML based analytics 
    • Deep patient clinical and molecular phenotyping data sets 
    • Novel biomarkers for patient segmentation including digital and imaging biomarkers 
  • Novel therapies with clear precision medicine strategy to address a defined patient segment 
  • Enabling technologies for clinical trials: 
    • Potential solutions aiming to identify and recruit specific patient sub-populations 
    • Potential solutions aiming to resolve technical issues associated with large scale PBMC collection and preparation for multiomics analysis 
    • High dimensional blood immune profiling platforms (e.g., cellular, autoantibodies, complement, proteomics, exosomes, mass spec) 
    • Tissue based single cell RNA sequencing 

Click here to learn more!

Share this article:


Last Updated: 11/9/21